Typical Atrial Flutter Research Articles

A patient-based realistic simulation platform to train future electrophysiologists to complex ablation procedures

Abstract Title An immersive catheter ablation platform based on patients’ 3D heart model for the simulation and training of future electrophysiologists. Background Arrhythmias are on the rise worldwide due to the ageing of the population. Projections urge to train the next generation of electrophysiologists (EPs) to perform catheter (CATH) ablation (CA) of arrhythmias. Training of future EPs relies mostly on a companionship, where teaching of CATH steerability is made on patients (pts) referred for procedures. While several other domains have established the utility of simulators to speed up learning process, increase safety and establish procedure road maps, dedicated simulators for EPs based on pts’ real anatomy do not exist yet. Purpose To speed up the handling of steerable CATH on MRI-based 3D heart models to optimize ablation road maps in pts referred for complex arrhythmias. Methods ARTS is an Artificial Intelligence and Augmented Reality-based platform comprising two key components: HeARTS and ARTSim. HeARTS is designed to automatically generate 3D heart models from pts’ MRI scans. ARTSim is a CA simulator that utilizes the 3D heart models of the pts for the planning and simulation of CA procedures. This simulator incorporates innovative techniques for digitizing and tracking the movements of a physical catheter in real time, and enabling its navigation within a completely virtual heart. With this technology, the CATH can be precisely steered to various heart locations, including the right and left (LA) atrium, the coronary sinus, and the right and left (LV) ventricles. Results Panel A of the figure shows the mannequin used for the simulator, where a real ablation CATH is introduced within the pt’s heart through a venous introducer. Panel B shows right anterior oblique (RAO) and modified RAO views of a pt suffering from a typical right atrial flutter. Note the presence of yellow tags positioned along the cavotricuspid isthmus (CTI) that the trainee must reach for a programmable duration using the shaft and the handle of the CATH shown in panel A. Panel C shows the virtual ablation CATH in green positioned on the target dots of the CTI. The pink color indicates that the trainee reached the desired target, which became red when the CATH remained stable at the same location for a duration of 5 sec (i.e. stability) with a force >5g (i.e. efficacy) and <20g (i.e. safety). Conclusions Herein, we present ARTS, a realistic CA simulation platform for the training of future EPs, that offers all the typical characteristics of 3D navigation including steerability, stability measurements and the force applied. Importantly, ARTS is based on the true anatomy of the pts, hence might be used to establish and discuss roadmaps to optimize procedures efficacy and safety. Version 2.0, foreseen early 2024, will include 3D late gadolinium enhancement and transseptal puncture for virtual LA and LV procedures, and later on activation times and myocardial voltage.Figure

Evaluation of the cavotricuspid isthmus contractile kinetics within an interventional CMR environment

Abstract Background Cavotricuspid isthmus (CTI)-dependent flutter is a common arrhythmia with recurrences following ablation up to 50%. Previous static morphological analysis have shown that CTI anatomical variability has an impact on ablation time and procedural success. However, whether the contractile kinetics of the CTI affect procedural success remains unknown to date. Purpose Assessment of the contractile kinetics of the CTI in a cardiac magnetic resonance (CMR) environment for patients (pts) referred for typical flutter ablation. Method 32 consecutive pts with typical right atrial (RA) flutter from our Heart Center were included in this study. RA wall contours during a single cardiac cycle were delineated on CMR 2D-images using the Tomtec software. CTIs were divided in 5 segments for detailed motion analysis as shown in the figure 1A. CTI length and displacement were measured both in caudo-cranial and postero-anterior directions. Quantification of the CTI kinetics was performed in Python by computing the 2D-Euclidean distance (between two extreme temporal positions of CTI points). Results The mean CTI length of the study population (mean age 66±10 years, 29 males) was 32±13 mm during RA systole and 49±15 mm during RA diastole, resulting in a mean CTI change of 17±7 mm over one cardiac cycle (maximum – minimum length). Figure 1A shows representative MRI views of the CTI during RA systole and diastole. Figure 1B shows examples of hypo- and hyperkinetics CTI from 2 representative pts. Figure 2C shows a gradual increase in segment displacement postero-anteriorly (8.1±7.3 vs 17.2±8.1 mm, p<0.05) and caudo-cranially (1.6±0.8 vs 4.5±2.4 mm) from the Eustachian valve toward the Tricuspid valve. Figure 2D indicates that the 2D-Euclidean displacement of the 5 segments varied between 8±7.7 mm and 18±8.5 mm depending on their location. Interestingly, the overall CTI displacement was 4.5 times greater forward than upward. Conclusion To our knowledge, this is the first study investigating the kinetics properties of the CTI in sinus rhythm of patients with typical RA flutter. The CTI showed displacements both in postero-anterior and caudo-cranial directions, with a gradual increase from the Eustachian to the Tricuspid valves. CTI displacement appeared highly variable across patients. Whether the kinetics of the CTI correlate with ablation success will be investigated shortly.

Feasibility and safety of cavotricuspid isthmus ablation using exclusive intracardiac echocardiography guidance: a proof-of-concept, observational trial

Abstract Introduction Catheter ablation is the preferred treatment for typical atrial flutter (AFl), although it can pose challenges due to anatomical abnormalities. The integration of 3D electroanatomical mapping systems (EAMS) has notably diminished the need for fluoroscopy in AFl ablation procedures. Intracardiac echocardiography (ICE) has also demonstrated advantages in reducing radiation exposure during AFl ablation. Nevertheless, there is a lack of evidence on the feasibility of ICE-guided, zero-fluoroscopy AFl ablation without the use of EAMS. Methods In this prospective study, we enrolled 80 patients with CTI-dependent AFl. The initial 40 patients underwent ablation guided by standard fluoroscopy along with ICE (Standard ICE group), whereas the remaining 40 patients underwent zero-fluoroscopy ablation exclusively using ICE (Zero ICE group). Procedure outcomes, including acute success, procedural duration, fluoroscopy duration, radiation dose, and any associated complications, were compared between the groups. Results Both groups achieved a 100% acute success rate. In the Zero ICE group, the zero-fluoroscopy approach was successfully executed in 39 out of 40 cases (97.5%). There were no significant differences in procedure time (55.5 (46.5; 66.8) min vs. 51.5 (44.0; 65.5), p=0.50) and puncture to first ablation time (18 (13.5; 23) min vs. 19 (15; 23.5) min, p=0.50) between the groups. The Zero ICE group had significantly lower fluoroscopy time (57 (36.3; 90) sec vs. 0 (0; 0) sec, p<0.001) and dose (3.17 (2.27; 5.63) mGy vs. 0 (0; 0) mGy, p<0.001 compared to the Standard ICE group. Total ablation time was longer in the Standard ICE group (597 (447; 908) sec vs. 430 (260; 750), p=0.02), but total ablation energy (22458 (14836; 31116) Ws vs. 17043 (10533; 29302) Ws, p=0.10) did not differ significantly. First-pass bidirectional conduction block of the CTI and acute reconnection rates were comparable between the groups. No complications or recurrences were noted during the follow-up period. Conclusion ICE-guided, zero-fluoroscopy CTI ablation for AFl using only ICE is feasible and safe. This method effectively eliminates radiation exposure without compromising procedural duration, total ablation time, or acute success rates.isthmus ablation by ICE

Optimizing outcomes in catheter ablation for typical atrial flutter: a comparative study of intracardiac echocardiography versus fluoroscopy guidance

Abstract Background Catheter ablation is a standard intervention for typical atrial flutters, specifically targeting the cavotricuspidal isthmus (CTI). Intracardiac echocardiography (ICE) plays a pivotal role in providing real-time visualization of anatomical structures during the electrophysiology procedure, thereby enhancing safety and potentially reducing reliance on fluoroscopy, leading to improved procedural outcomes. We aimed to conduct a comparative analysis of procedural and follow-up outcomes between ICE-guided and fluoroscopy-only guided catheter ablations for CTI in patients undergoing treatment for typical atrial flutter. Methods A retrospective analysis was conducted at our university center, encompassing 376 consecutive patients in a single-center study. Of these, 158 underwent procedures guided solely by fluoroscopy, while 218 received ICE-guided CTI ablation. Results ICE-guidance demonstrated a statistically significant reduction in fluoroscopy time (72 [36; 170] s vs. 888 [578; 1184] s; p<0.01), total procedure time (70 [52; 90] min vs. 90 [60; 105] min; p<0.01), total ablation time (692 [435; 998] s vs. 920 [629; 1373] s; p<0.01), and the duration from the first to last ablation (20.5 [12; 37] min vs. 41.0 [26.8; 59.3] min; p<0.01). Both groups achieved a 100% acute success rate without major complications. The ICE-guided group exhibited a significantly superior long-term success rate (ICE-guided group: 95.74%, fluoroscopy-only group: 89.26%; p=0.048) compared to the fluoroscopy-only group at an average follow-up length of 34 months. Conclusion The utilization of ICE-guidance for CTI ablation significantly reduces fluoroscopy exposure, procedure time, and ablation time, ultimately contributing to enhanced long-term success rates when compared to the conventional fluoroscopy-only approach.

Validation of bidirectional cavotricuspid isthmus block using electrocardiographic imaging

Abstract Background The validation of bidirectional cavotricuspid isthmus (CTI) block following catheter ablation for typical atrial flutter (AFL) involves endocavitary manoeuvres using multiple catheters. The diagnostic capacity of electrocardiographic imaging (ECGi) as a non-invasive tool to confirm bidirectional CTI block may simplify the procedure but its benefit has not been investigated so far. Purpose To evaluate the diagnostic capacities of a novel imageless ECGi system in detecting bidirectional CTI block during AFL catheter ablation. Methods A total of 34 patients were consecutively included in a prospective single-centre study. Atrial activation maps were derived from a novel imageless ECGi system when pacing the septal and lateral aspects of the CTI, gauging the technology's capacities to detect bidirectional block by measuring transisthmic intervals (TII) and observing wave-front collision patterns. TII reflects the time taken for electrical activation to cross the CTI during pacing and we measured both the absolute value and the increase relative to its baseline value. The bidirectional CTI block was assessed by endocavitary manoeuvres using a multipole catheter as the gold-standard. We conducted a blind assessment of the diagnostic capacities of ECGi over endocavitary manoeuvres considering maps from the septal and lateral pacing to determine clockwise and counterclockwise CTI block, respectively. Results Our study established clear benchmarks for diagnosing CTI block using ECGi (Figure 1). Regarding the assessment of clockwise CTI block, the presence of a wave-front collision pattern at the CTI yielded a positive predictive value (PPV) of 91% and negative predictive value (NPV) of 69%. Furthermore, ROC analysis pinpointed 100 ms and 30 ms as the optimal threshold for TII absolute value (PPV=89%, NPV =78%) and TII increase from baseline (PPV=91%, NPV =65%), respectively. Taking together, the combination of these three parameters offered high diagnostic capacities (PPV=87%, NPV=90%). Regarding counterclockwise CTI block, the TII absolute value alone was a reliable predictor, with a threshold derived from ROC analysis of 115 ms providing a PPV of 77% and a NPV of 83% (Graphical abstract). Conclusion These results highlight the efficacy of ECGi in CTI block assessment, promising a streamlined and accurate diagnostic approach (Graphical abstract). The use of a single ablation catheter coupled with ECGi to assess the bidirectional CTI block offers a simplified and efficient alternative to traditional dual catheter techniques.ECGi-based CTI block assessment methodGraphical abstract

Using the impedance map to identify non-conductive structures during cavo-tricuspidal isthmus ablation

Abstract Background The ablation of the cavo-tricuspidal isthmus (CTI) is often affected by the anatomical variability of structures made of non-conductive tissue (NCS): the Eustachian valve, tricuspid valve leaflet and Tebesio's valve, the presence of which may be associated with failure of the isthmic block despite a large number of erogations and post-ablation recurrences. Since these structures have different conductive properties from atrial tissue, it is plausible that they are characterised by their own tissue impedance, and can therefore be identified through an impedance map. Objectives The objectives of the study were: 1) to characterise CTI by impedance map, in order to identify NCS; 2) to perform ablation of CTI aimed at isolating only conductive tissue by combining impedance map with the Maximum Voltage Gradient (MVG) technique, in order to evaluate the efficacy of this strategy in acute and during follow-up. Methods From 01/2021 to 09/2023 impedance map and CTI substrate map was performed, without the use of fluoroscopy, in all patients undergoing ablation of typical atrial flutter. A 15-ohm impedance reduction from the mean atrial impedance was considered the cut-off for defining the presence of NCS. Substrate maps were constructed according to the MVG technique (0.5-2.5 mV thresholds), in particular looking for high-voltage channels in which the impedance map detected the presence of NCS. Ablation was performed only in the high-voltage channels (W45, AI500). Results Our study included 48 patients with a mean age of 68±13 years, with 92% of them being men. The mean volume of the right atrium was 153 mL, and the mean number of points per map was 1205. With the use of impedence map, we were able to identify the presence of NCS in 25 patients (52%). The distribution of non conductive structures and the mean voltage by quadrants can be seen in Figures B-C. Importantly, we found that the mean number of radiofrequency applications required to achieve isthmic block was significantly lower in patients with identified NCS compared to those without (6.3 vs. 10; p=0.007). In 60% of the patients with NCS, radiofrequency was administered in high-voltage channels that were detected in the quadrant where the NCS was present (odds ratio 3.42, p=0.04). Furthermore, we successfully achieved acute isthmic blockade in all patients, and there were no instances of recurrence during a mean follow-up period of 186 days. Conclusions Our findings demonstrate that the combination of Impedence Map and the Maximum Voltage Gradient technique is an effective approach for achieving isthmic block with a reduced number of radiofrequency applications. The identification of NCS allows for a more precise search for high-voltage channels, enabling ablations to be performed in optimal contact with the tissue. This meticulous approach is crucial for the success of the procedure.

PROMINENT CRISTA TERMINALIS AND ATRIAL FLUTTER: CASE REPORT

Abstract Introduction Crista terminalis is a fibromuscular ridge at the posterolateral region of the right atrium (RA). Prominent crista terminalis can mimic pathologic RA mass on transthoracic echocardiograms. Transesophageal echocardiography can be used to differentiate non pathologic structures from pathologic ones. Case Report A 51–year–old men was referred to our clinic with typical atrial flutter. Transthoracic echocardiogram (TTE) revealed a RA mass. It was round, 15 mm in diameter, immobile, not calcified, and located at the posterior region of RA. Transesophageal echocardiography (TEE) showed prominent crista terminalis superiorly located beneath superior vena cava in the RA at 91 degrees midesophageal position. The patient undergoes catheter ablation for typical atrial flutter. Discussion Several congenital structures and normal variants such as Chiari’s network, eustachian and thebesian valves, and atrial septal aneurysms may simulate pathologic RA masses such as RA thrombus or myxomas. However, in this case, an anatomical variant is associated with an arrhythmia that requires treatment. Conclusion In this case we want to emphasize that prominent crista terminalis can mimic RA mass and may lead to atrial arrhythmias. TEE can be used to differentiate normal structures from pathologic.

Development and validation of the Atri-Risk Conduction Index risk score to predict risk of atrial fibrillation after typical atrial flutter ablation

BackgroundIdentification of patients at risk for atrial fibrillation (AF) after typical atrial flutter (tAFL) ablation is important to guide monitoring and treatment. ObjectiveThe purpose of this study was to create and validate a risk score to predict AF after tAFL ablation MethodsWe identified patients who underwent tAFL ablation with no AF history between 2017 and 2022 and randomly allocated to derivation and validation cohorts. We collected clinical variables and measured conduction parameters in sinus rhythm on an electrophysiology recording system (CardioLab, GE Healthcare). Univariate and multivariate logistic regressions (LogR) were used to evaluate association with AF development. ResultsA total of 242 consecutive patients (81% male; mean age 66 ± 11 years) were divided into derivation (n =142) and validation (n = 100) cohorts. Forty-two percent developed AF over median follow-up of 330 days. In multivariate LogR (derivation cohort), proximal to distal coronary sinus time (pCS-dCS) ≥70 ms (odds ratio [OR] 16.7; 95% confidence interval [CI] 5.6–49), pCS time ≥36 ms (OR 4.5; 95% CI 1.5–13), and CHADS2-VASc score ≥3 (OR 4.3; 95% CI 1.6–11.8) were independently associated with new AF during follow-up. The Atri-Risk Conduction Index (ARCI) score was created with 0 as minimal and 4 as high-risk using pCS-dCS ≥70 ms = 2 points; pCS ≥36 ms = 1 point; and CHADS2-VASc score ≥3 = 1 point. In the validation cohort, 0% of patients with ARCI score = 0 developed AF, whereas 89% of patients with ARCI score = 4 developed AF. ConclusionWe developed and validated a risk score using atrial conduction parameters and clinical risk factors to predict AF after tAFL ablation. It stratifies low-, moderate-, and high-risk patients and may be helpful in individualizing approaches to AF monitoring and anticoagulation.

Typical Atrial Flutter in acute coronary syndrome with ST segment elevation: incidence, predictive factors and related mortality.

Background: Typical Atrial Flutter in acute coronary syndrome with ST segment elevation is very rare and never reported as a separate electrocardiographic entity, but associated with atrial fibrillation. Its incidence isn’t reported in the literature, and no data about its predictive factors or related mortality, also its epidemiological data is lacking in Algeria. Aims: The main objective of our study is the determination of the frequency of typical atrial flutter in acute coronary syndrome with ST segment elevation, the secondary objective was the analysis of its predictive factors, and related mortality. Methods and materials: In this prospective study, conducted in the cardiology department of Hussein Dey hospital (Algiers-Algeria), 467 patients with acute coronary syndrome with elevated ST segment (87 women and 380 men) were enrolled between 28 February 2014 and 16 July 2015. The average age is 60 ± 13 years; at admission, a Holter recorder was attached for continuous ECG monitoring during 48 hours Kruskal’s ANNOVA or H tests were used for comparison of quantitative variables, χ2 test or Fisher’s exact test, were used for qualitative variables, all tests were performed with 1st species risk of 5%. Results: The frequency of typical atrial flutter is 0.4 % (2 patients), CI 95%: [0%-1%], multivariate analysis identified right heart failure as the only predictive factor. The risk of mortality expressed by Hazard Ration (HR) is 27 (CI95%: [3.5-207], p = 0.001); right heart failure is the only predictive factor of mortality identified in our study. Conclusion: typical atrial flutter is very rare in acute coronary syndrome with elevated ST segment, its predictive factor according to our study is right heart failure, and its occurrence increases the risk of hospital mortality.

Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results.

Contact force (CF)-sensing radiofrequency (RF) catheters with an ablation index have shown reproducible outcomes for the treatment of atrial fibrillation (AF) in large multicentre studies. A dual-energy (DE) focal CF catheter to deliver RF and unipolar/biphasic pulsed field ablation (PFA), integrated with a three-dimensional (3D) mapping system, can provide operators with additional flexibility. The SmartfIRE study assessed the safety and efficacy of this novel technology for the treatment of drug-refractory, symptomatic paroxysmal AF. Results at 3 months post-ablation are presented here. Pulmonary vein isolation (PVI) was performed using a DE focal, irrigated CF-sensing catheter with the recommendation of PFA at posterior/inferior and RF ablation at the anterior/ridge/carina segments. Irrespective of energy, a tag size of 3 mm; an inter-tag distance ≤6 mm; a target index of 550 for anterior, roof, ridge, and carina; and a target index of 400 for posterior and inferior were recommended. Cavotricuspid isthmus ablation was permitted in patients with documented typical atrial flutter. The primary effectiveness endpoint was acute procedural success. The primary safety endpoint was the rate of primary adverse events (PAEs) within 7 days of the procedure. A prespecified patient subset underwent oesophageal endoscopy (EE; 72 h post-procedure), neurological assessment (NA; pre-procedure and discharge), and cardiac computed tomography (CT)/magnetic resonance angiogram (MRA) imaging (pre-procedure and 3 months post-procedure) for additional safety evaluation, and a mandatory remapping procedure (Day 75 ± 15) for PVI durability assessment. Of 149 patients enrolled between February and June 2023, 140 had the study catheter inserted (safety analysis set) and 137 had ablation energy delivered (per-protocol analysis set). The median (Q1/Q3) total procedure and fluoroscopy times were 108.0 (91.0/126.0) and 4.2 (2.3/7.7) min (n = 137). The acute procedural success rate was 100%. First-pass isolation was achieved in 89.1% of patients and 96.8% of veins. Cavotricuspid isthmus ablations were successfully performed in 12 patients [pulsed field (PF) only: 6, RF only: 5, and RF/PF: 1]. The PAE rate was 4.4% [6/137 patients; 2 pulmonary vein (PV) stenoses, 2 cardiac tamponades/perforations, 1 stroke, and 1 pericarditis]. No coronary artery spasm was reported. No oesophageal lesion was seen in the EE subset (0/31, 0%). In the NA subset (n = 30), microemboli lesions were identified in 2 patients (2/30, 6.7%), both of which were resolved at follow-up; only 1 was symptomatic (silent cerebral lesion, 3.3%). In the CT/MRA subset (n = 30), severe PV narrowing (of >70%) was detected in 2 patients (2/30, 6.7%; vein level 2/128, 1.6%), of whom 1 underwent dilatation and stenting and 1 was asymptomatic; both were associated with high index values and a small inter-tag distance. In the PV durability subset (n = 30), 100/115 treated PVs (87%) were durably isolated and 18/30 patients (60.0%) had all PVs durably isolated. A DE focal CF catheter with 3D mapping integration showed a 100% acute success rate with an acceptable safety profile in the treatment of paroxysmal AF. Prespecified 3-month remapping showed notable PVI durability. ClinicalTrials.gov Identifier: NCT05752487.

The Effect of the Use of Activation 3D Mapping on the Patient X-Ray Load During Radiofrequency Ablation of Typical Atrial Flutter

Supraventricular macro re-entry tachyarrhythmias occupy the leading places among all types of tachyarrhythmias. The most common in this category is typical atrial flutter (AFL). This heart rhythm disorder has a negative impact on the patients’ quality of life. Its complications can lead to disability and death due to possible thromboembolism. Therapeutic treatment is limited in effectiveness. The main method of intervention is catheter radiofrequency ablation (RFA). The standard approach of RFA of AFL is performed without the use of navigation systems under fluoroscopy guidance. However, this results in an increased radiation exposure to the patient and the medical personnel. Modern technologies in the field of invasive electrophysiology make it possible to create anatomical models of heart and reproduce the spread of electrical excitation. However, the routine use of additional navigation methods remains controversial.
 The aim. To compare the duration of RFA of typical AFL and radiation exposure with the use of anatomical and propagation mapping.
 Materials and methods. This study is based on the analysis of the treatment results obtained for 53 patients at the National Amosov Institute of Cardiovascular Surgery in the period from 2014 to 2023. Depending on imaging methods, the patients were divided into two groups. The first group included 27 patients with an anatomical mapping of the right atrium. The second group included 26 patients with propagation mapping.
 Results. In all the patients we have achieved a bidirectional conduction block through cavotricuspid isthmus. In the first group, the total duration of confirming the diagnosis and creating the anatomical model was 312 ± 26 seconds. The mean time to the moment of AFL termination and restoration of sinus rhythm was 230 ± 19 seconds. The average duration of the procedure was 41.5 ± 3.5 minutes, the average fluoroscopy time was 120 ± 10 seconds, the average dose area product (DAP) was 15 ± 1.3 Gy·cm2. In the second group, the average time for creating a 3D propagation model of right atrium and verifying the diagnosis was 748 ± 65 seconds. The average time from the first application to the termination of tachycardia was 227 ± 20 seconds. The average duration of the procedure was 55 ± 4.7 minutes, X-ray time was 93 ± 8 seconds, average DAP was 13 ± 1.1 Gy·cm2. The duration of the procedure in the second group was significantly longer (p = 0.03), however, the radiation exposure and DAP were not statistically different (p = 0.31) between the observation groups.
 Conclusions. The use of propagation mapping increases the time of the procedure by 24.5% and does not give a significant advantage in reducing the radiation exposure. The use of a navigation system during cavotricuspid isthmus RFA is recommended for concomitant radical treatment of complex supraventricular arrhythmias, such as atrial fibrillation.

Cryoballoon pulmonary vein isolation as first-line treatment of typical atrial flutter: long-term outcomes of the CRAFT trial

BackgroundCRAFT was an international, multicentre, randomised controlled trial across 11 sites in the United UK and Switzerland. Given the evidence that pulmonary vein triggers may be responsible for atrial flutter (AFL) as well as atrial fibrillation (AF), we hypothesised that cryoballoon pulmonary vein isolation (PVI) would provide greater symptomatic arrhythmia reduction than cavotricuspid isthmus (CTI) ablation, whilst also reducing the subsequent burden of AF. Twelve-month outcomes were previously reported. In this study, we report the extended outcomes of the CRAFT study to 36 months.MethodsPatients with typical AFL and no evidence of AF were randomised 1:1 to cryoballoon PVI or radiofrequency CTI. All patients received an implantable loop recorder (ILR) for continuous cardiac rhythm monitoring. The primary outcome was time-to-symptomatic arrhythmia recurrence > 30 s. Secondary outcomes included time-to-first-AF episode ≥ 2 min. The composite safety outcome included death, stroke and procedural complications.ResultsA total of 113 patients were randomised to cryoballoon PVI (n = 54) or radiofrequency CTI ablation (n = 59). Ninety-one patients reconsented for extended follow-up beyond 12 months. There was no difference in the primary outcome between arms, with the primary outcome occurring in 12 PVI vs 11 CTI patients (HR 0.97; 95% CI 0.43–2.20; p = 0.994). AF ≥ 2 min was significantly less frequent in the PVI arm, affecting 26 PVI vs 36 CTI patients (HR 0.48; 95% CI 0.29–0.79; p = 0.004). The composite safety outcome occurred in 5 PVI and 6 CTI patients (p = 0.755).ConclusionCryoballoon PVI shows similar efficacy to radiofrequency CTI ablation in reducing symptomatic arrhythmia recurrence in patients presenting with isolated typical AFL but significantly reduces the occurrence of subsequent AF.Graphical

Enormous Enlargement of Right Atrium Occurred Late After Surgical Dilation of Pulmonary Valve Stenosis: Case Report.

Congenital pulmonary valve stenosis is a relatively common congenital defect, often related to abnormal development and fusion of pulmonary valves. Critical pulmonary valve stenosis should be treated, early in life, before dilation of right chambers, and occurrence of arrhythmias. We report one case of enormous enlargement of right atrium revealed by typical atrial flutter which occurred very late, in 48-year-old man, who underwent surgical dilation of pulmonary valve stenosis at eleven years old, but without repairing dilated tricuspid annulus. Despite successfully ablation of atrial flutter in our cathlab, the patient developed atrial fibrillation, because of an enormous enlargement of right atrium and massive tricuspid regurgitation.

Patho-specific assessment of the quality of life using the ASTA protocol after radiofrequency ablation for atrial tachyarrhythmias

Atrial tachyarrhythmias cause highly symptomatic conditions and have a negative impact on the patients’ quality of life (QoL). In the management of such patients, it is particularly important to consider not only objective indicators, but also the subjective well-being of patients and their everyday life. The patho-specific questionnaire for assessing the QoL is the ASTA symptom scale. The aim of the work was to conduct a patho-specific assessment of the QoL using the ASTA protocol after radiofrequency ablation (RFA) for atrial tachyarrhythmias on the example of performed cavo-tricuspid isthmus (CTI) RFA among patients with typical atrial flutter. Materials and methods. In total, 135 patients from the National Amosov Institute of Cardiovascular Surgery were asked to complete the ASTA questionnaire before CTI RFA and during two follow-up visits in the period from 2014 to 2021. To assess the patients’ QoL, a statistical analysis was performed in accordance with the 6th part of chapters 2 and 3. Results. When analyzing complaints, statistically significant changes were found in all aspects compared to the initial state (p < 0.05). The most noticeable changes were related to the anxiety level and heart failure manifestations, in particular, dyspnea on exertion and at rest, weakness and exhaustion (p < 0.0001). The least but also statistically significant changes were associated with comorbid pathologies. Analyzing the third chapter, positive statistically significant dynamics were observed in all characteristics during the control period. After RFA, the patients reported improvements in their QoL, decreased level of depression and restored physical activity (p < 0.0001). There was also a significant improvement in social life, as there were no more restrictions in spending time with relatives and friends (p < 0.0001). In addition, there was an improvement in the ability to concentrate and in the working capacity (p < 0.0001). Conclusions. Atrial tachyarrhythmias significantly affect the QoL of patients, including their emotional, physical state and social integration, worsening the daily lives of the study participants.

A Simple Score to Predict New-Onset Atrial Fibrillation After Ablation of Typical Atrial Flutter

BackgroundNew-onset atrial fibrillation (NeAF) is common after cavotricuspid isthmus-dependent counterclockwise atrial flutter (CCW-AFL) ablation. This study aimed to investigate a simple predictive model of NeAF after CCW-AFL ablation. MethodsFrom January 2013, to December 2017, consecutive patients receiving CCW-AFL ablation were enrolled from 3 centres. Clinical, echocardiographic, and electrocardiographic data were collected and followed. Patients from 2 centres and another centre were assigned into the derivation and validation cohorts, respectively. In the derivation cohort, logistic regression was performed to evaluate the ability of parameters to discriminate those with and without NeAF. A score system was developed and then validated. ResultsTwo hundred seventy-one patients (mean 59.7 ± 13.6 age; 205 male) were analyzed. During follow-up (73.0 ± 6.5 months), 107 patients (39.5%) had NeAF; 190 and 81 patients were detected in the derivation and validation cohorts, respectively. Hypertension, age ≥ 70 years, left atrial diameter ≥ 42 mm, P-wave duration ≥ 120 ms and the negative component of flutter wave in lead II ≥ 120 ms were selected as the final parameters. A weighted score was used to develop the HAD-AF score ranging from 0 to 9. In the derivation cohort, area under the receiver operating characteristic curve (AUC) was 0.938 (95% confidence interval [CI], 0.902-0.974), superior to those of currently used CHA2DS2-VASC (0.679, 95% CI, 0.600-0.757) and HATCH scores (0.651, 95% CI, 0.571-0.730) (P < 0.001). Performance maintained in the validation cohort. ConclusionsSix years after CCW-AFL ablation, 39.5% of patients developed NeAF. HAD-AF score can reliably identify patients likely to develop NeAF after CCW-AFL ablation.

Navigating the risk of atrial fibrillation after successful ablation of lone typical atrial flutter.

Navigating the risk of atrial fibrillation after successful ablation of lone typical atrial flutter.

Focal Pulsed Field Ablation for Atrial Arrhythmias: Efficacy and Safety under Deep Sedation.

Focal pulsed field ablation (PFA) is a novel technique for treating cardiac arrhythmias. It has demonstrated positive results in initial studies and has a good safety profile. In recent studies, PFA was often utilized for first-time pulmonary vein isolation (PVI) and was performed under general anesthesia. In our study, we assessed the feasibility, safety, acute procedural efficacy, and efficiency of focal PFA under deep sedation in patients, 80% of whom had undergone at least one left atrial ablation previously. We treated 30 patients (71 ± 7, 46% male) using the CENTAURI system for various atrial arrhythmias, including atrial fibrillation, typical and atypical atrial flutter, and focal atrial tachycardia. The average procedure and fluoroscopy times were 122 ± 43 min and 9 ± 7 min, respectively. A total of 83.33% of patients received additional line ablations beyond PVI, specifically targeting the posterior box and anterior mitral line. All ablations were successfully performed in deep sedation with only one major and one minor complication observed. The major complication was a vasospasm of the right coronary artery during ablation of the cavotricuspid isthmus, which was treated successfully with intracoronary nitroglycerin. All patients could be discharged in sinus rhythm. Moreover, adenosine appears effective in identifying dormant conduction in some patients after focal PFA. In conclusion, focal PFA is an effective approach for complex left atrial ablations under deep sedation, offering both high efficacy and efficiency with a reliable safety profile. Studies on long-term outcomes are needed.

Intraoperative atrial rhythm changes during atrial fibrillation catheter ablation in patients with arterial hypertension and coronary artery disease

Atrial fibrillation is a rhythm disorder with an extensive etiology and not fully understood pathogenesis. Catheter ablation is an effective way to control the rhythm of atrial fibrillation. The results of catheter ablation differ in patients with various comorbidities of the cardiovascular system. Intraoperative changes in the atrial rhythm can be a criterion for the long-term effectiveness of the operation or determine the need for additional effects.Aim: To assess intraoperative changes in atrial rhythm during catheter ablation of atrial fibrillation in patients with concomitant pathology of the cardiovascular system.Methodology and research methods. The results of catheter ablation of 451 patients with paroxysmal and persistent atrial fibrillation were analyzed retrospectively for the period from 2016 to 2017. After clinical and anamnestic data analysis, 151 patients with primary isolation of the pulmonary veins were selected. Depending on the concomitant pathology of the cardiovascular system, patients were divided into 3 groups: group 1 – with idiopathic atrial fibrillation, group 2 – atrial fibrillation in combination with isolated essential arterial hypertension and group 3 – atrial fibrillation in combination with ischemic heart disease.Results. In patients with idiopathic atrial fibrillation, relief of atrial fibrillation with sinus rhythm preservation until the end of surgery was more often observed than in patients with ischemic heart disease (22% vs. 10,6%, р = 0,021). In patients with ischemic heart disease, typical atrial flutter was much more common and there was a need to perform radiofrequency ablation of the cavothricuspid isthmus in addition to isolation of the pulmonary veins (47,9% vs. 18,8% 1 Group 1, р = 0,005, and 24,7% in Group 2, р = 0,01).Conclusions. The concomitant pathology of the cardiovascular system in patients affects the dynamics of the atrial rhythm during catheter treatment of atrial fibrillation and may take into account the definition of intraoperative tactics.

Corrected sinus node recovery time as a screening test in patients with typical atrial flutter post-ablation to predict pacemaker implantation

Corrected sinus node recovery time as a screening test in patients with typical atrial flutter post-ablation to predict pacemaker implantation

Corrected sinus node recovery time as a screening test in patients with typical atrial flutter post-ablation to predict pacemaker implantation.

The objective of the study was to establish the prognostic value of CSNRT regarding the necessity for pacemaker implantation in patients with atrial flutter (AFL) post-ablation. This prospective cohort study, conducted at the National Institute of Cardiology "Ignacio Chavez" in Mexico City, assessed patients who had undergone ablation procedures to correct AFL, posterior to which an autonomic blockade was performed, and CSNRT was measured. The sample for this investigation was 40 patients. These were subdivided into two study groups depending on their requirement of pacemaker implant post-ablation (Pacemaker P, No Pacemaker NP). Sinus node (SN) dysfunction was diagnosed in 13 (32.5%) of the 40 participants, 10 (71.43%) of which required a pacemaker implant, while only 4 participants (28.57%) with normal SN function required pacemakers. Ten out of the 14 patients (71.43%) who required a pacemaker had an elevated CSNRT > 500 ms (p ≤ 0.01). Post-ablation CSNRT mean was 383.54 ms ± 67.96 ms in the NP group versus 1972.57 ms ± 3423.56 ms in the P group. Furthermore, SN pause in the P group had a mean of 1.86 s ± 0.96 s versus the NP group with 1.196 s ± 0.52 s. CSNRT has the potential to be a quantitative prognostic tool for the assessment of future pacemaker implants in patients with AFL post-ablation. This could aid in the timely diagnosis of sinus node dysfunction, which could, in the long run, result in the reduction of cardiac functional capacity loss due to cardiac remodeling.